Benzinga's Top Pre-Market Gainers

Lexicon Pharmaceuticals LXRX surged 21.99% to $2.33 in the pre-market session. Lexicon Pharmaceuticals reported positive results of LX4211 Phase 2b trial for type 2 diabetes. Teva Pharmaceutical Industries Limited TEVA added 6.87% to $40.62 in the pre-market session. Teva reported favorable court ruling in COPAXONE® patent infringement litigation. Watson Pharmaceuticals WPI moved up 2.37% to $72.70 in the pre-market session. Watson Pharmaceuticals entered into a new senior secured term loan facility in an aggregate principal amount of $1.8 billion.. SanDisk SNDK soared 1.35% to $36.85 in the pre-market trading. Analysts at Goldman Sachs upgraded SanDisk from “neutral” to “buy.”